Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
(MENAFN- GlobeNewsWire - Nasdaq) The Global API market is expanding due to rising chronic diseases, demand for generics post-patent expirations, and R&D investments. There are opportunities in ...